Publicis

DEAR HEALTH (CONT’D)

20/09/22 -"Over the last three years, AlphaValue has been on a mission to call Health stocks expensive. That segment excludes Pharmas. The sector is down 30%, of which 7% over the last week. That still leaves ..."

PDF page sample
Pages
52
Language
English
Published on
20/09/22
Download
You may also be interested by these reports :
21/01/26
Since our last teaser, Informa’s (ADD; UK) share price performance has been good in absolute terms despite the end of the covid catch-up in B2B ...
20/01/26
Informa published a slightly above expectations FY25 trading update and confirmed its clever partnership with Dubai World Trade Center (DWTC) via the ...
14/01/26
Pearson announced an FY25 trading update in line with strong performance in Assessments and Enterprise Learning & Skills, supported by the ...
10/12/25
The target price adjustment is due to the removal of IPG from the peer group, following the delisting from the stock market on 28 November 2025.

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO